
Kauser M. Akhoon
Examiner (ID: 9527, Phone: (571)270-1026 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1613 |
| Total Applications | 267 |
| Issued Applications | 151 |
| Pending Applications | 2 |
| Abandoned Applications | 116 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9798670
[patent_doc_number] => 20150010613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/912960
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13790
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13912960
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/912960 | Compositions and methods for cancer immunotherapy | Jun 6, 2013 | Issued |
Array
(
[id] => 10267193
[patent_doc_number] => 20150152190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'Prostate-Specific Membrane Antigen Antibody Drug Conjugates'
[patent_app_type] => utility
[patent_app_number] => 14/406190
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 74164
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406190
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/406190 | Prostate-specific membrane antigen antibody drug conjugates | Jun 6, 2013 | Issued |
Array
(
[id] => 10887730
[patent_doc_number] => 08911719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'Tamper resistant dosage forms'
[patent_app_type] => utility
[patent_app_number] => 13/901218
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 65997
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901218
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/901218 | Tamper resistant dosage forms | May 22, 2013 | Issued |
Array
(
[id] => 9068183
[patent_doc_number] => 20130259938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'TAMPER RESISTANT DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 13/900933
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 66008
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900933
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900933 | TAMPER RESISTANT DOSAGE FORMS | May 22, 2013 | Abandoned |
Array
(
[id] => 9054084
[patent_doc_number] => 20130251798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'TAMPER RESISTANT DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 13/900963
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 65956
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900963
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900963 | Tamper resistant dosage forms | May 22, 2013 | Issued |
Array
(
[id] => 9068259
[patent_doc_number] => 20130260015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'TAMPER RESISTANT DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 13/900873
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 65983
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900873
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900873 | Tamper resistant dosage forms | May 22, 2013 | Issued |
Array
(
[id] => 9710362
[patent_doc_number] => 08834925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Tamper resistant dosage forms'
[patent_app_type] => utility
[patent_app_number] => 13/901122
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 66036
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901122
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/901122 | Tamper resistant dosage forms | May 22, 2013 | Issued |
Array
(
[id] => 11059604
[patent_doc_number] => 20160256566
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2016-09-08
[patent_title] => 'METHOD FOR PRODUCING LIPOSOME ENCAPSULATING PACLITAXEL MONOGLYCOSIDE AND/OR DOCETAXEL MONOGLYCOSIDE'
[patent_app_type] => utility
[patent_app_number] => 14/386855
[patent_app_country] => US
[patent_app_date] => 2013-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12730
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14386855
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/386855 | Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside | Mar 21, 2013 | Issued |
Array
(
[id] => 11059604
[patent_doc_number] => 20160256566
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2016-09-08
[patent_title] => 'METHOD FOR PRODUCING LIPOSOME ENCAPSULATING PACLITAXEL MONOGLYCOSIDE AND/OR DOCETAXEL MONOGLYCOSIDE'
[patent_app_type] => utility
[patent_app_number] => 14/386855
[patent_app_country] => US
[patent_app_date] => 2013-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12730
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14386855
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/386855 | Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside | Mar 21, 2013 | Issued |
Array
(
[id] => 9560700
[patent_doc_number] => 20140178413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'COMPOUNDS AND METHODS FOR THE TREATMENT OF ERB B2/NEU POSITIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/837187
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13565
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13837187
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/837187 | COMPOUNDS AND METHODS FOR THE TREATMENT OF ERB B2/NEU POSITIVE DISEASES | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9735976
[patent_doc_number] => 20140271689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'Therapeutic Cancer Vaccine Targeted to HAAH (Aspartyl-[Asparaginyl]-beta-Hydroxylase)'
[patent_app_type] => utility
[patent_app_number] => 13/836487
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4157
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13836487
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/836487 | Therapeutic Cancer Vaccine Targeted to HAAH (Aspartyl-[Asparaginyl]-beta-Hydroxylase) | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9560697
[patent_doc_number] => 20140178411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'COMPOUNDS AND METHODS FOR THE TREATMENT OF CD20 POSITIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/834726
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12070
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13834726
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/834726 | COMPOUNDS AND METHODS FOR THE TREATMENT OF CD20 POSITIVE DISEASES | Mar 14, 2013 | Abandoned |
Array
(
[id] => 11611462
[patent_doc_number] => 09649305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'PFKFB3 inhibitor and methods of use as an anti-cancer therapeutic'
[patent_app_type] => utility
[patent_app_number] => 14/388983
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8769
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388983
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388983 | PFKFB3 inhibitor and methods of use as an anti-cancer therapeutic | Mar 13, 2013 | Issued |
Array
(
[id] => 9280360
[patent_doc_number] => 20140030327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'TAMPER RESISTANT DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 13/803132
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 65932
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13803132
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/803132 | TAMPER RESISTANT DOSAGE FORMS | Mar 13, 2013 | Abandoned |
Array
(
[id] => 9041188
[patent_doc_number] => 20130243826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'TOPICAL COMPOSITIONS FOR USE IN THE CONTROL OF SEXUALLY TRANSMITTED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/801993
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3073
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801993
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/801993 | TOPICAL COMPOSITIONS FOR USE IN THE CONTROL OF SEXUALLY TRANSMITTED DISEASES | Mar 12, 2013 | Abandoned |
Array
(
[id] => 10259492
[patent_doc_number] => 20150144490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'Methods and Compositions for Preparing Biological Specimens for Microscopic Analysis'
[patent_app_type] => utility
[patent_app_number] => 14/403050
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 21064
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403050
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403050 | Methods and compositions for preparing biological specimens for microscopic analysis | Mar 12, 2013 | Issued |
Array
(
[id] => 8915880
[patent_doc_number] => 20130177505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'DERMAL REJUVENATION COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/783930
[patent_app_country] => US
[patent_app_date] => 2013-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8849
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13783930
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/783930 | Dermal rejuvenation compositions and methods | Mar 3, 2013 | Issued |
Array
(
[id] => 10255001
[patent_doc_number] => 20150139998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'NOVEL CELL WALL POLYMERS OF ENTEROCOCCUS FAECALIS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/387753
[patent_app_country] => US
[patent_app_date] => 2013-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7943
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14387753
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/387753 | Cell wall polymers of Enterococcus faecalis and uses thereof | Mar 3, 2013 | Issued |
Array
(
[id] => 9634266
[patent_doc_number] => 20140212374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'ANTIBACTERIAL IMIDAZOLIUM COMPOUND AND ANTIBACTERIAL PHOTOCURABLE THIOL-ENE COMPOSITIONS COMPRISING THE SAME, AND ANTIBACTERIAL POLYMER COATINS PREPARED THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 13/768373
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7189
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13768373
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/768373 | Antibacterial imidazolium compound and antibacterial photocurable thiol-ene compositions comprising the same, and antibacterial polymer coatins prepared therefrom | Feb 14, 2013 | Issued |
Array
(
[id] => 9641830
[patent_doc_number] => 20140219941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'COSMETIC POWDER COATED WITH ALGINIC ACID AND METHODS OF MAKING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/761133
[patent_app_country] => US
[patent_app_date] => 2013-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9895
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13761133
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/761133 | COSMETIC POWDER COATED WITH ALGINIC ACID AND METHODS OF MAKING THE SAME | Feb 5, 2013 | Abandoned |